Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis.
Cyriac S, Prem S, Salas MQ, Chen S, Al-Shaibani Z, Lam W, Law A, Gupta V, Michelis FV, Kim DDH, Lipton J, Kumar R, Mattsson J, Viswabandya A.
Cyriac S, et al. Among authors: prem s.
Eur J Haematol. 2021 Nov;107(5):517-528. doi: 10.1111/ejh.13689. Epub 2021 Jul 27.
Eur J Haematol. 2021.
PMID: 34260760